Search research articles
Contact Us
Filters
Showing results (1431-1440 of 1,773) with videos related to
Page
of 178
Sort By:
Plos Biology
|
June 12, 2018
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation
Jing Zhao, Lei Zhang, Xiaodong Mu, et al.
Nature Communications
|
April 26, 2019
Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
D Merino, T S Weber, A Serrano, et al.
Nature Communications
|
February 17, 2019
Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
D Merino, T S Weber, A Serrano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2015
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
V Bossuyt, E Provenzano, W F Symmans, et al.
The EMBO Journal
|
June 23, 2014
Molecular mechanism of ligand recognition by membrane transport protein, Mhp1
Katie J Simmons, Scott M Jackson, Florian Brueckner, et al.
ACS Chemical Biology
|
September 24, 2015
Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors
Samer O Abdul-Hay, Thomas D Bannister, Hui Wang, et al.
JCO Oncology Practice
|
January 22, 2025
Musician's Experience After Breast Cancer Treatment: Defining Musical Toxicity and its Frequency
Jessica F Burlile, Joshua D Cameron, Heather J Gunn, et al.
Cancer Research
|
February 12, 2022
A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non-Small Cell Lung Cancer
Jieun Son, Jaebong Jang, Tyler S Beyett, et al.
Cell
|
June 11, 2025
MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastoma
Rajappa S Kenchappa, Laszlo Radnai, Erica J Young, et al.
ACS Chemical Biology
|
September 24, 2021
Discovery of Selective Inhibitors for <i>In Vitro</i> and <i>In Vivo</i> Interrogation of Skeletal Myosin II
Laszlo Radnai, Matthew Surman, Madalyn Hafenbreidel, et al.
Page
of 178
Search research articles
Search
Showing results (1431-1440 of 1,773) with videos related to
Sort By:
Page
of 178
Plos Biology
|
June 12, 2018
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation
Jing Zhao, Lei Zhang, Xiaodong Mu, et al.
Nature Communications
|
April 26, 2019
Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
D Merino, T S Weber, A Serrano, et al.
Nature Communications
|
February 17, 2019
Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
D Merino, T S Weber, A Serrano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2015
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
V Bossuyt, E Provenzano, W F Symmans, et al.
The EMBO Journal
|
June 23, 2014
Molecular mechanism of ligand recognition by membrane transport protein, Mhp1
Katie J Simmons, Scott M Jackson, Florian Brueckner, et al.
ACS Chemical Biology
|
September 24, 2015
Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors
Samer O Abdul-Hay, Thomas D Bannister, Hui Wang, et al.
JCO Oncology Practice
|
January 22, 2025
Musician's Experience After Breast Cancer Treatment: Defining Musical Toxicity and its Frequency
Jessica F Burlile, Joshua D Cameron, Heather J Gunn, et al.
Cancer Research
|
February 12, 2022
A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non-Small Cell Lung Cancer
Jieun Son, Jaebong Jang, Tyler S Beyett, et al.
Cell
|
June 11, 2025
MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastoma
Rajappa S Kenchappa, Laszlo Radnai, Erica J Young, et al.
ACS Chemical Biology
|
September 24, 2021
Discovery of Selective Inhibitors for <i>In Vitro</i> and <i>In Vivo</i> Interrogation of Skeletal Myosin II
Laszlo Radnai, Matthew Surman, Madalyn Hafenbreidel, et al.
Page
of 178